Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ESLA Estrella Immunopharma

休市中 06-05 16:00:00 EDT

1.14

-0.01

-0.87%

盘后1.14

+0.000.00%

19:37 EDT

最高1.15	最低1.10	成交量6,707
今开1.15	昨收1.15	日振幅4.34%
总市值4,906万	流通市值2,054万	总股本4,303万
成交额7,519	换手率0.04%	流通股本1,802万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ESLA","market":"US","secType":"STK","nameCN":"Estrella Immunopharma","latestPrice":1.14,"timestamp":1780689600000,"preClose":1.15,"halted":0,"volume":6707,"hourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.14,"latestTime":"19:37 EDT","volume":63,"amount":71.82,"timestamp":1780702622373,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.008695652173913052,"floatShares":18021500,"shares":43034228,"eps":-0.345949,"marketStatus":"休市中","change":-0.01,"latestTime":"06-05 16:00:00 EDT","open":1.1499,"high":1.15,"low":1.1001,"amount":7518.502063100001,"amplitude":0.043391,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.345949,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1780905600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":1.15,"preHourTrading":{"tag":"盘前","latestPrice":1.17,"preClose":1.15,"latestTime":"09:28 EDT","volume":10,"amount":11.7,"timestamp":1780666101001,"change":0.02,"changeRate":0.017391,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":1.14,"preClose":1.14,"latestTime":"19:37 EDT","volume":63,"amount":71.82,"timestamp":1780702622373,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.11139974718615495},"requestUrl":"/m/hq/s/ESLA","defaultTab":"news","newsList":[{"id":"2618956961","title":"Estrella Immunopharma, Inc.盘中异动 早盘急速拉升6.54%报1.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618956961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618956961?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:57","pubTimestamp":1773068262,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日22时57分，Estrella Immunopharma, Inc.股票出现异动，股价快速拉升6.54%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，An2 Therapeutics, Inc.、Xenon制药、Relmada Therapeutics, Inc.涨幅较大，Relmada Therapeutics, Inc.、An2 Therapeutics, Inc.、Edesa Biotech, Inc.较为活跃，换手率分别为39.77%、29.36%、25.45%，振幅较大的相关个股有An2 Therapeutics, Inc.、Aditxt, Inc.、Polaryx Therapeutics, Inc.，振幅分别为47.72%、37.17%、35.76%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603092257429546273c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603092257429546273c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617859521","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨7.17%报1.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617859521","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617859521?lang=zh_cn&edition=full","pubTime":"2026-03-04 23:28","pubTimestamp":1772638100,"startTime":"0","endTime":"0","summary":"北京时间2026年03月04日23时28分，Estrella Immunopharma, Inc.股票出现异动，股价大幅上涨7.17%。截至发稿，该股报1.17美元/股，成交量1557股，换手率0.00%，振幅1.83%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.48%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304232820954303d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304232820954303d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613724568","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速跳水5.69%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613724568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613724568?lang=zh_cn&edition=full","pubTime":"2026-02-21 00:12","pubTimestamp":1771603946,"startTime":"0","endTime":"0","summary":"北京时间2026年02月21日00时12分，Estrella Immunopharma, Inc.股票出现异动，股价大幅下挫5.69%。截至发稿，该股报1.16美元/股，成交量1.526万股，换手率0.04%，振幅3.24%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。Estrella 的使命是利用人类免疫系统的进化力量来改变癌症和自身免疫性疾病患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602210012279541898c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602210012279541898c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102194995","title":"Estrella Immunopharma完成800万美元注册直接发行与同步私募配售","url":"https://stock-news.laohu8.com/highlight/detail?id=1102194995","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102194995?lang=zh_cn&edition=full","pubTime":"2026-01-07 03:02","pubTimestamp":1767726148,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma（股票代码：ESLA）宣布成功完成800万美元的注册直接发行及同步进行的私募配售。此次融资将用于推进公司核心免疫疗法管线的临床开发，增强企业资本结构。通过结合公开市场发行与私募融资的双轨策略，公司展现了在复杂市场环境中灵活获取资本的执行能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLAW","ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601869472","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.06%报1.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601869472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601869472?lang=zh_cn&edition=full","pubTime":"2026-01-05 22:33","pubTimestamp":1767623580,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日22时33分，Estrella Immunopharma, Inc.股票出现异动，股价急速上涨5.06%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223301953c03ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223301953c03ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141368458","title":"Estrella Immunopharma公司宣布800万美元注册直接发行及同步私募配售，按纳斯达克规则以市价定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1141368458","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141368458?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:30","pubTimestamp":1767619823,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma公司已正式披露一项融资计划，将实施总额800万美元的注册直接发行，并同步开展私募配售。此次发行的定价将严格遵循纳斯达克市场规则，采用市价定价机制。该举措旨在为公司的免疫药物研发及业务拓展注入新的资金动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594094264","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨6.58%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594094264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594094264?lang=zh_cn&edition=full","pubTime":"2025-12-25 01:23","pubTimestamp":1766596990,"startTime":"0","endTime":"0","summary":"北京时间2025年12月25日01时23分，Estrella Immunopharma, Inc.股票出现异动，股价急速拉升6.58%。截至发稿，该股报1.62美元/股，成交量6300股，换手率0.02%，振幅4.61%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122501231097a0a771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122501231097a0a771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113157198","title":"Estrella Immunopharma - 提供高达2,541,206股的转售机会给售股股东 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1113157198","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113157198?lang=zh_cn&edition=full","pubTime":"2025-12-22 23:58","pubTimestamp":1766419092,"startTime":"0","endTime":"0","summary":"Estrella Immunopharma - 提供高达2,541,206股的转售机会给售股股东 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588032226","title":"Estrella Immunopharma, Inc.盘中异动 早盘大幅跳水5.21%报2.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588032226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588032226?lang=zh_cn&edition=full","pubTime":"2025-12-01 22:51","pubTimestamp":1764600673,"startTime":"0","endTime":"0","summary":"北京时间2025年12月01日22时51分，Estrella Immunopharma, Inc.股票出现波动，股价急速下跌5.21%。截至发稿，该股报2.00美元/股，成交量2.5864万股，换手率0.07%，振幅9.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.66%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201225113a71d2844&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251201225113a71d2844&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518720833","title":"Estrella Immunopharma, Inc.盘中异动 大幅跳水8.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518720833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518720833?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:22","pubTimestamp":1741623768,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时22分，Estrella Immunopharma, Inc.股票出现波动，股价快速下跌8.84%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Mineralys Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Aeon Biopharma, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Aeon Biopharma, Inc.、Scisparc Ltd.较为活跃，换手率分别为3707.85%、3218.00%、951.39%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 29/04/2026 、Aeon Biopharma, Inc.、Scisparc Ltd.，振幅分别为88.14%、78.32%、49.87%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002248964058fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311002248964058fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517298859","title":"Estrella Immunopharma, Inc.盘中异动 股价大涨5.88%报1.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517298859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517298859?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:36","pubTimestamp":1741206965,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时36分，Estrella Immunopharma, Inc.股票出现波动，股价大幅上涨5.88%。截至发稿，该股报1.08美元/股，成交量1.7955万股，换手率0.05%，振幅7.84%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为1.92%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043605a2612c13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043605a2612c13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516637380","title":"Estrella Immunopharma, Inc.盘中异动 早盘快速下跌5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637380?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:49","pubTimestamp":1741013384,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时49分，Estrella Immunopharma, Inc.股票出现波动，股价快速跳水5.83%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032249449637b1a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032249449637b1a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514376386","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大涨5.19%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514376386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514376386?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:16","pubTimestamp":1740755776,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时16分，Estrella Immunopharma, Inc.股票出现波动，股价大幅拉升5.19%。截至发稿，该股报1.010美元/股，成交量1.0893万股，换手率0.03%，振幅1.04%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823161698968437&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022823161698968437&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514387460","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514387460","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514387460?lang=zh_cn&edition=full","pubTime":"2025-02-28 00:41","pubTimestamp":1740674497,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日00时41分，Estrella Immunopharma, Inc.股票出现异动，股价大幅跳水5.45%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004137a25699d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228004137a25699d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514517618","title":"Estrella Immunopharma, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514517618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514517618?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:48","pubTimestamp":1740581335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时48分，Estrella Immunopharma, Inc.股票出现异动，股价大幅下跌5.17%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.28%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224856abddf181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224856abddf181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514182740","title":"Estrella Immunopharma, Inc.盘中异动 早盘股价大跌6.78%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514182740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514182740?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:45","pubTimestamp":1740494729,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时45分，Estrella Immunopharma, Inc.股票出现异动，股价急速跳水6.78%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Adial Pharmaceuticals, Inc涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为875.90%、636.03%、533.95%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.，振幅分别为100.27%、46.65%、33.50%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224530abdc81c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224530abdc81c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513751722","title":"Estrella Immunopharma, Inc.盘中异动 大幅跳水18.18%报1.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513751722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513751722?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:31","pubTimestamp":1740407517,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时31分，Estrella Immunopharma, Inc.股票出现异动，股价急速跳水18.18%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223157a2521459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223157a2521459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513909762","title":"D. Boral Capital：维持Estrella Immunopharma(ESLA.US)评级，由买入调整至买入评级, 目标价由16.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513909762","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513909762?lang=zh_cn&edition=full","pubTime":"2025-02-22 00:51","pubTimestamp":1740156681,"startTime":"0","endTime":"0","summary":"D. Boral Capital：维持Estrella Immunopharma(ESLA.US)评级，由买入调整至买入评级, 目标价由16.00美元调整至16.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22005148320974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ESLA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296581","title":"Estrella Immunopharma, Inc.股价飙升13.42% 市值涨820.54万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296581?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148262,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Estrella Immunopharma, Inc.股票出现异动，股价大幅上涨13.42%。截至发稿，该股报1.69美元/股，成交量10.6477万股，换手率0.29%，振幅0.00%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223102a24eaff6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223102a24eaff6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ESLA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512166470","title":"Estrella Immunopharma, Inc.盘中异动 快速上涨12.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166470","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166470?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:32","pubTimestamp":1739889130,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时32分，Estrella Immunopharma, Inc.股票出现波动，股价快速拉升12.15%。Estrella Immunopharma, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Glycomimetics, Inc.涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为276.23%、91.16%、60.68%，振幅较大的相关个股有Allogene Therapeutics, Inc.、Cns Pharmaceuticals, Inc.、Allakos Inc.，振幅分别为9.56%、8.57%、8.35%。Estrella Immunopharma, Inc.公司简介：Estrella Immunopharma Inc 是一家临床阶段的生物制药公司，开发针对 CD19 和 CD22 的 ARTEMIS T 细胞疗法，用以解决血癌和实体瘤患者的治疗挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223210a24aacc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223210a24aacc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ESLA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.estrellabio.com","stockEarnings":[{"period":"1week","weight":0.0459},{"period":"1month","weight":-0.1231},{"period":"3month","weight":0.0654},{"period":"6month","weight":-0.4271},{"period":"1year","weight":0.0755},{"period":"ytd","weight":-0.2692}],"compareEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":0.0051},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.0756},{"period":"1year","weight":0.2437},{"period":"ytd","weight":0.0816}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Estrella Immunopharma, Inc.于2022年3月30日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，利用其专有的ARTEMIS技术开发针对血液癌症和实体瘤的T细胞疗法。其主要候选药物EB103靶向CD19用于治疗B细胞恶性肿瘤，同时也在开发双靶向候选药物EB104。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.071617},{"month":2,"riseRate":0.6,"avgChangeRate":-0.002484},{"month":3,"riseRate":0.4,"avgChangeRate":-0.005084},{"month":4,"riseRate":0.8,"avgChangeRate":0.114262},{"month":5,"riseRate":0.2,"avgChangeRate":-0.099189},{"month":6,"riseRate":0.6,"avgChangeRate":0.023188},{"month":7,"riseRate":0.5,"avgChangeRate":0.07367},{"month":8,"riseRate":0.25,"avgChangeRate":-0.054345},{"month":9,"riseRate":0.75,"avgChangeRate":0.07408},{"month":10,"riseRate":0.6,"avgChangeRate":-0.005756},{"month":11,"riseRate":0.8,"avgChangeRate":0.071826},{"month":12,"riseRate":0.2,"avgChangeRate":-0.109506}],"exchange":"NASDAQ","name":"Estrella Immunopharma","nameEN":"Estrella Immunopharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Estrella Immunopharma,ESLA,Estrella Immunopharma股票,Estrella Immunopharma股票老虎,Estrella Immunopharma股票老虎国际,Estrella Immunopharma行情,Estrella Immunopharma股票行情,Estrella Immunopharma股价,Estrella Immunopharma股市,Estrella Immunopharma股票价格,Estrella Immunopharma股票交易,Estrella Immunopharma股票购买,Estrella Immunopharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Estrella Immunopharma(ESLA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Estrella Immunopharma(ESLA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}